Incidence and Healthcare Resource Utilization Among Patients with Hypertrophic Cardiomyopathy Hospitalized for Heart Failure in Japan [0.03%]
日本住院心力衰竭患者的肥厚型心肌病患病率和医疗资源利用状况
Yuika Ikeda,Bruno Casaes Teixeira,Thomas Laurent et al.
Yuika Ikeda et al.
Introduction: Heart failure (HF) is one of the most common complications in patients with hypertrophic cardiomyopathy (HCM); however, there are limited data on HCM burden in Japan. We evaluated the burden of HF hospitaliz...
Beyond Blood Sugar: A Scoping Review of GLP-1 Receptor Agonists in Cardiovascular Care [0.03%]
超越血糖：心血管护理中GLP-1受体激动剂作用的范畴评审
Neil Gupta,Zaid Zayyad,Rohan Bhattaram et al.
Neil Gupta et al.
Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) have emerged as a transformative class of therapies initially developed for glycemic control in type 2 diabetes mellitus. Now, they are also getting recognized for their broader cardiome...
Survival in a Contemporary, Real-World Cohort of Patients with Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis: An Analysis from THAOS [0.03%]
来自THAOS的混合表型转甲状腺素蛋白淀粉样变性心肌病患者的当代、真实世界队列生存分析：tafamidis治疗患者的分析结果
Jonas Wixner,Angela Dispenzieri,Leslie Amass et al.
Jonas Wixner et al.
Introduction: Tafamidis is approved to treat transthyretin amyloid cardiomyopathy (ATTR-CM). Many patients with ATTR-CM present with a mixed phenotype of both cardiac and neurologic symptoms, but real-world effectiveness ...
Safety and Effectiveness of Apixaban in Very Elderly Patients with Atrial Fibrillation: A Retrospective Analysis of Japanese Administrative Claims Data [0.03%]
阿哌沙班治疗房颤的日本老年人群回顾性研究：基于保险理赔数据的安全性和有效性分析
Ako Matsuo-Ohsawa,Jun Katada,Shun Kohsaka
Ako Matsuo-Ohsawa
Introduction: Anticoagulation is a well-established treatment for patients with atrial fibrillation (AF) for the prevention of stroke/systemic embolism (SE). However, although nearly all elderly patients with AF are at ri...
Cracking the Zip Code: Uncovering the Link Between Socioeconomic Status and Transcatheter Aortic Valve Replacement Outcomes [0.03%]
破解邮政编码：揭开社会经济状态与经导管主动脉瓣置换术结局之间联系的面纱
Helena Dickens,Adhir Shroff,Khaled Abdelhady et al.
Helena Dickens et al.
Introduction: There is a well-known correlation between lower socioeconomic status and health outcomes. Patient zip codes and the Centers for Disease Control and Prevention's (CDC) Social Vulnerability Index (SVI) can be ...
Association Between Insulin Resistance and Incomplete Endothelization of LAAC Devices in Patients with Atrial Fibrillation: A Retrospective Study [0.03%]
房颤患者经皮左心耳封堵术后器械不完整内皮化的代谢危险因素分析：一项回顾性研究
Jing Zhou,En Zhou,Qing He et al.
Jing Zhou et al.
Introduction: Incomplete endothelialization (IDE) of left atrial appendage closure (LAAC) devices increases the risk of device-related thrombosis (DRT) and stroke. Insulin resistance (IR) may contribute to IDE by impairin...
Utility of Screening Fetal Echocardiograms Following Normal Level II Ultrasounds in Fetuses with Siblings with Congenital Heart Disease [0.03%]
正常II水平超声后的胎儿筛查心动图在有先天性心脏病兄弟姐妹的胎儿中的作用
Kacy Taylor,Casey Lovelace,Erin Van Pelt et al.
Kacy Taylor et al.
Introduction: In pregnancies when congenital heart disease (CHD) is present in siblings, fetal echocardiograms (F-echo) are recommended, regardless if there was a prior level II ultrasound (LII-US) that was normal. The go...
Correction: Rationale and Design of ANTHOLOGY: An ATTR Amyloidosis Real-World Evidence Program Aiming to Address Gaps in Amyloidosis Care [0.03%]
ANTHOS研究的纠正：ATTR淀粉样变性真实世界证据项目的理据和设计——弥合护理缺口
Julian D Gillmore,Katrin Hahn,J Gustav Smith et al.
Julian D Gillmore et al.
Published Erratum
Cardiology and therapy. 2025 May 24. DOI:10.1007/s40119-025-00417-5 2025
Safety and Efficacy of Tafamidis in Chinese Patients with Transthyretin Amyloid Cardiomyopathy [0.03%]
腾喜乐治疗中国甲状腺素转运蛋白心脏淀粉样变患者的疗效和安全性
Zhuang Tian,Daoquan Peng,Wei Ma et al.
Zhuang Tian et al.
Introduction: Tafamidis is approved in many countries for the treatment of patients with transthyretin amyloid cardiomyopathy (ATTR-CM). Approval is largely based on findings from an international phase 3 trial. This post...
Correction: Prevalence, Patient Characteristics, and Treatment of Patients with Hypertrophic Cardiomyopathy: A Nationwide Payer Database Study [0.03%]
纠正：肥厚型心肌病患者的患病率，患者特征和治疗情况：一项全国付费数据库研究
Yuika Ikeda,Tsunehisa Yamamoto,Makio Torigoe et al.
Yuika Ikeda et al.
Published Erratum
Cardiology and therapy. 2025 May 20. DOI:10.1007/s40119-025-00414-8 2025